English: Despite the challenges of recent years, we have several stories of success here in Wales, and these will work as catalysts to achieve our target. We've already mentioned about the opt-out tests for blood-borne viruses that were introduced in Swansea prison in 2016. By doing this, we succeeded in having micro-elimination in the prison - the first in the UK to do that. And this was featured in the report that you wrote as a committee. By now, there is a strategy in place in Berwyn prison as well, and Public Health Wales has ensured funding to be introduced in Cardiff prison. The aim is to eliminate the virus in all of the prisons in Wales in the longer term. On top of that, there is a Follow Me support programme and it's aimed at raising awareness. And under that plan, staff from the voluntary sector, from the Hepatitis C Trust, will be working within the clinical pathway, with people who they see as challenging, to try and seek help from health services, and will be encouraging them to have IgG tests. The project is being trialled at present in Cardiff and Vale University Health Board, with awareness-raising work in homeless shelters happening in Cardiff, and further training for staff to be introduced in terms of service users. We're fortunate that the hepatitis C clinical network is very effective and dedicated here in Wales. This leads to the saving of more than £40 million in drug treatments since anti-viral agents, which operate directly, were introduced in 2014. It's a flexible way of funding drugs and providing them to patients, and improves the patient experience, improves outcomes and helps to save costs as well. Even though we're all aware of the great work that's been done already, and that we still have to do, to meet the target of eradicating the virus by 2030, we're continuing to work with the health service here in Wales to deliver our aim jointly, and our aim is to give you a further update in the autumn. Thank you.
Welsh: Er gwaethaf heriau'r blynyddoedd diwethaf, mae gyda ni sawl stori o lwyddiant yma yng Nghymru, ac fe fydd y rhain yn gweithio fel catalydd i gyflawni ein targed. Rŷn ni wedi sôn yn barod am y profion optio allan ar gyfer feirysau a gludir yn y gwaed, a gafodd eu cyflwyno yng ngharchar Abertawe yn 2016. A thrwy wneud hyn, llwyddwyd i sicrhau micro-elimination yn y carchar - y cyntaf yn y Deyrnas Unedig i wneud hynny. Mae hwn yn rhywbeth a oedd yn yr adroddiad wnaethoch chi ei ysgrifennu fel pwyllgor. Erbyn hyn, mae strategaeth ar waith yng ngharchar Berwyn hefyd, ac mae Iechyd Cyhoeddus Cymru wedi sicrhau cyllid i'w gyflwyno yng ngharchar Caerdydd. Y nod yw cael gwared ar y feirws yn holl garchardai Cymru yn y tymor hirach. Ar ben hynny, mae cynllun cefnogol Follow Me yn ddull sefydledig o godi ymwybyddiaeth. O dan y cynllun hwn, mae staff o'r sector gwirfoddol, o Ymddiriedolaeth Hepatitis C, yn gweithio o fewn y llwybr clinigol, gyda phobl sy'n ei gweld yn heriol, i geisio help gan wasanaethau iechyd, ac yn eu hannog i gael eu profi a'u trin. Mae'r prosiect yn cael ei dreialu ar hyn o bryd ym Mwrdd Iechyd Prifysgol Caerdydd a'r Fro, gyda gwaith codi ymwybyddiaeth mewn hosteli'r digartref yng Nghaerdydd, ac mae hyfforddiant pellach i staff i gael ei gyflwyno o safbwynt defnyddwyr gwasanaeth. Rŷn ni'n ffodus bod rhwydwaith clinigol hepatitis C yn hynod o effeithiol ac yn ymroddedig yma yng Nghymru. Mae hyn yn arwain at arbed mwy na £40 miliwn mewn triniaethau cyffuriau ers i gyfryngau gwrthfeirol - anti-viral agents - sy'n gweithredu'n uniongyrchol, gael eu cyflwyno yn 2014. Mae'n ffordd hyblyg o ariannu cyffuriau a'u darparu i gleifion, yn gwella profiad y claf, gan wella canlyniadau a helpu i arbed costau hefyd. Er ein bod ni gyd yn ymwybodol o'r gwaith sylweddol sydd wedi'i wneud, ac sydd i'w wneud eto, i wireddu ein targed o ddileu'r feirws erbyn 2030, rŷn ni'n parhau i weithio â'r gwasanaeth iechyd yma yng Nghymru i gyflawni ein nod ar y cyd, a'n nod yw rhoi diweddariad pellach i chi yn yr hydref. Diolch.